Search for: "Pfizer Inc." Results 1 - 20 of 1,510
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
26 Feb 2024, 6:41 am by Robin E. Kobayashi
The IMR reviewer noted that applicant had a history of auditory hallucinations, which were ameliorated with Geodon, demonstrating the efficacy of that medication and supporting its medical necessity. [ LexisNexis Commentary: This IMR is particularly interesting because the medication Geodon, which was at issue here, was the subject of a $301 million settlement between Pfizer, Inc. and the U.S. [read post]
12 Feb 2024, 4:30 am by Tom Kosakowski
The current CO-OP directors and officers are: Mollie Berg, CO-OP, President (National Geospatial-Intelligence Agency)Suzanne Diviney, CO-OP, Secretary (Pfizer Inc.)Amarah Khan, CO-OP, Treasurer (City of Seattle) Allison Whaley, CO-OP, Director (Montgomery College)Dan Marcotte, CO-OP, Director (Federal Deposit Insurance Corp.)Diana Trillos, CO-OP Candidate, Director (World Bank Group )In addition, IOA and the CO-OP Board recently announced that a joint task force is developing a new… [read post]
1 Feb 2024, 9:39 am by Mark Ashton
Typically, they earn a salary far less than their brethren at Merck, Pfizer, IBM or DuPont. [read post]
11 Jan 2024, 12:03 am by Kurt R. Karst
The FIE determination released in fall 2023 involves the Reference Product AbbVie’s Humira (adalimumab) and two interchangeable biosimilars—first approved is Cyltezo (adalimumab-adbm), filed by Boehringer Ingelheim Pharmaceuticals, Inc, which was followed by Abrilada (adalimumab-afzb), filed by Pfizer. [read post]
28 Dec 2023, 12:56 pm by David W.S. Lieberman
 Pfizer then made “donations” to the foundation to cover the copays. [read post]
20 Oct 2023, 6:37 am by Shane McCall
Pfizer Inc Agrees to Pay $2M to Resolve Alleged Compensation Discrimination at New York City Location SBA Administrator Guzman and Business Leaders Reaffirm Support for 8(a) Program If it does get passed, the Defense authorization bill has quite a few surprises Florida International University Agress to Pay $575K in Back Wages, Interest to Resolve Alleged Gender Pay Discrimination Former Navy IT Manager Sentenced to over 5 Years in Prison for Hacking a Computer… [read post]
19 Oct 2023, 8:59 am by Robin E. Kobayashi
[LexisNexis Commentary: This IMR is particularly interesting because the medication Geodon, which was at issue here, was the subject of a $301 million settlement between Pfizer, Inc. and the U.S. [read post]
31 Aug 2023, 11:01 am by John Holtz
As for vendors, naturally the top vendors are almost all giants, such as Pfizer, Lockheed Martin, and Raytheon. [read post]
29 Aug 2023, 4:15 am by Eileen McDermott
Pfizer, Inc. and BioNTech SE on Monday hit back at competitor COVID-19 vaccine maker Moderna with inter partes review (IPR) petitions against two Moderna patents on mRNA vaccine technology at the Patent Trial and Appeal Board (PTAB). [read post]
29 Aug 2023, 4:15 am by Eileen McDermott
Pfizer, Inc. and BioNTech SE on Monday hit back at competitor COVID-19 vaccine maker Moderna with inter partes review (IPR) petitions against two Moderna patents on mRNA vaccine technology at the Patent Trial and Appeal Board (PTAB). [read post]
10 Jul 2023, 6:47 am by Unknown
The SEC also brought charges against five individuals, including a Massachusetts police chief, in connection with their trading before the announcement of an offer by Alexion Pharmaceuticals Inc. to acquire Portola Pharmaceuticals Inc. [read post]
29 Jun 2023, 8:21 am by Mark Astarita
The Securities and Exchange Commission today announced insider trading charges against Amit Dagar, a former Pfizer Inc. employee, and his close friend and business partner, Atul Bhiwapurkar, for trading in advance of the company’s November 5, 2021,…Read the Full Press Release Have a securities law question? [read post]
20 Jun 2023, 5:55 am by Jennifer Papapanagiotou
Food and Drug Administration (FDA) issued two Emergency Use Authorizations (EUAs) for the Pfizer, Inc. and the ModernaTX, Inc. [read post]
9 Jun 2023, 8:36 am by Ashwin Varma
The Federal Trade Commission (FTC) recently announced that it would sue to block Amgen’s proposed $27.8 billion acquisition of Horizon Therapeutics. [read post]
9 Jun 2023, 8:36 am by Ashwin Varma
The Federal Trade Commission (FTC) recently announced that it would sue to block Amgen’s proposed $27.8 billion acquisition of Horizon Therapeutics. [read post]